News about Drug Discovery & Development

Bayer's Finerenone Shows Kidney and Cardiovascular Benefits in Hypertensive CKD Subgroup

New FIND-CKD data highlight finerenone’s potential to slow kidney disease progression and reduce cardiovascular-kidney risks in patients with hypertensive nephropathy.

Drug Discovery & Development | 01/09/2026 | By News Bureau |  154

Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

Rznomics joins Lilly Gateway Labs in San Diego to accelerate RNA therapeutics development, expand global partnerships and advance its pipeline of 200+ disease targets.

Drug Discovery & Development | 25/08/2026 | By News Bureau |  127

Dale Bredesen Proposes Pr2 Theory as New Framework for Understanding Alzheimer's and Neurodegeneration

Neuroscientist Dale E. Bredesen has proposed the Pr2 theory, a new framework that views neurodegeneration as a response to persistent biological stress and explores a precision-medicine approach to Alzheimer’s disease.

Drug Discovery & Development | 24/08/2026 | By News Bureau

Genprex Partners with US CDMO to Scale Up Diabetes Gene Therapy Manufacturing

Genprex has partnered with a US-based CDMO to scale up cGMP manufacturing of its AAV-based diabetes gene therapy candidate, supporting IND-enabling studies and future clinical trials.

Drug Discovery & Development | 19/08/2026 | By News Bureau |  114

TCS Launches AgentHub to Scale Agentic AI Across Drug Development

TCS has launched ADD AgentHub, an enterprise-ready agentic AI platform designed to transform clinical development and pharmacovigilance while maintaining human oversight, regulatory compliance and auditability.

Drug Discovery & Development | 18/08/2026 | By News Bureau |  174

FDA Clears Graviton BioScience's GV101 for Phase 2 Development in Friedreich's Ataxia

Graviton BioScience has received FDA IND clearance for a new GV101 capsule formulation, paving the way for a Phase 2 trial in patients with Friedreich’s ataxia.

Drug Discovery & Development | 12/08/2026 | By News Bureau |  441

Mediar Therapeutics, Ono Pharma Enter Collaboration to Develop Novel Fibrosis Therapies

Mediar Therapeutics and Ono Pharmaceutical have entered a collaboration and option agreement to discover novel therapies targeting fibro-inflammatory diseases, while Mediar advances its pipeline of fibrosis-focused antibody programmes.

Drug Discovery & Development | 10/08/2026 | By News Bureau |  133

BARDA Boosts Funding for Basilea's Investigational Oral Antibiotic Targeting Drug-Resistant UTIs

Basilea Pharmaceutica has secured an additional USD 5.4 million from BARDA to accelerate the development of its investigational oral antibiotic ceftibuten-ledaborbactam etzadroxil, a potential treatment for complicated urinary tract infections caused by multidrug-resistant Gram-negative pathogens.

Drug Discovery & Development | 06/08/2026 | By News Bureau |  151

Pathos AI, AstraZeneca Partner to Advance AI-Driven Breast Cancer Therapy into Clinical Development

Pathos AI and AstraZeneca have entered a strategic collaboration to advance AZD4241, an investigational therapy for ER+/HER2- breast cancer, using artificial intelligence to enhance clinical development and precision oncology.

Drug Discovery & Development | 05/08/2026 | By News Bureau |  199

ICAR Develops India's First Indigenous Vaccine Against African Swine Fever

The MA-104 cell line-based live attenuated vaccine offers cost-effective, large-scale protection against African swine fever, aiming to reduce pig mortality, safeguard farmers' livelihoods and strengthen India's animal health security.

Drug Discovery & Development | 05/08/2026 | By News Bureau |  156